← Back to Search

StrataXRT Arm for Breast Cancer

N/A
Recruiting
Led By Edward LW Chow, MBBS
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 3-months following radiation treatment
Awards & highlights

Study Summary

This trial is studying StrataXRT, a gel that may reduce skin reactions for breast cancer patients going through radiation treatment. Results from prior studies show it may reduce the size of skin reactions & improve skin color. A new pilot study will test it on 50 patients.

Eligible Conditions
  • Breast Cancer
  • Radiation Skin Damage

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 3-months following radiation treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 3-months following radiation treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute Coryza
Secondary outcome measures
Clinician satisfaction with StrataXRT
Acute Coryza
Cost analysis of StrataXRT
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: StrataXRT ArmExperimental Treatment1 Intervention
This is a single-arm trial where all patients will receive the intervention of StrataXRT.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
StrataXRT
2017
N/A
~450

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,550,572 Total Patients Enrolled
29 Trials studying Breast Cancer
16,086 Patients Enrolled for Breast Cancer
Edward LW Chow, MBBSPrincipal InvestigatorSunnybrook Health Sciences Centre
2 Previous Clinical Trials
246 Total Patients Enrolled
2 Trials studying Breast Cancer
246 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently taking part in this clinical experiment?

"Affirmative. The clinicaltrials.gov website attests that this research project is enrolling participants, having been initially published on October 13th 2022 and recently edited on October 25th 2022. This investigation requires the recruitment of 50 study members from a single location."

Answered by AI

Is there a current call for participants in this research program?

"Clinicaltrials.gov has attested to the fact that this particular medical trial is actively in search of participants, and was first listed on October 13th 2022 before being revised most recently on October 25th 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients
Dr. Edward Chow 2022. "A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05594498.
All > Seborrheic Dermatitis
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top